Henry G. Grabowski

Share Mark as favorite

Health Policy Outlook logo 80

As Congress considers legislation that would allow imitative biological products, known as “biosimilars,” to rely on the safety and efficacy data of original innovators, it must ensure that any provisions passed will foster, not stifle, discovery.

Share Mark as favorite

Ernst R. Berndt and Anjli C. Warner discuss their new book, U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies.

Share Mark as favorite

Share Mark as favorite

Share Mark as favorite

Share Mark as favorite

Share Mark as favorite

Share Mark as favorite

In this volume, Henry Grabowski and John Vernon examine the effect of the Vaccines for Children program on the incentives to invest in research and development for new and improved vaccines.

Share Mark as favorite

0844770264 130

This book discusses health care reform and how pharmaceutical innovations can be developed to ensure the healthy future of America.

No more entries available.

Sort By:

Refine Content:

Scholar

Additional Keywords:

Refine Results

or to save searches.

Open
Refine Content